Genetesis

About

Genetesis is a leading medical technology company based in Mason, Ohio, revolutionizing cardiac diagnostics through advanced magnetocardiography solutions. The company has developed CardioFlux, an innovative non-invasive technology that measures magnetic signals produced by the heart to detect myocardial ischemia in as little as five minutes. This breakthrough technology leverages four decades of proven scientific research to deliver rapid, dynamic cardiac diagnostic results without requiring stress testing or invasive procedures. CardioFlux has received both Health Canada approval and FDA 510(k) clearance for myocardial ischemia diagnosis, establishing Genetesis as a trusted partner for hospitals, emergency departments, and cardiology practices nationwide. The technology significantly reduces patient wait times and hospital observation periods while providing healthcare providers with critical diagnostic information needed for immediate treatment decisions. The company serves prestigious healthcare institutions including Ascension St. John Hospital, The Christ Hospital, Emory University, and Wake Forest Baptist Health. Genetesis focuses on transforming preventive cardiac care by offering healthcare providers a faster, less invasive alternative to traditional cardiac testing methods. Their magnetocardiography technology represents a significant advancement in cardiac diagnostics, enabling earlier detection of heart conditions and improved patient outcomes. Through continuous innovation and strategic partnerships with leading medical institutions, Genetesis continues to advance the field of cardiac diagnostics while maintaining the highest standards of quality and regulatory compliance in the healthcare technology sector.